Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan · Delayed Price · Currency is TWD 179.00
+1.50 (0.85%)
Sep 3, 2025, 11:59 AM CST
TPEX:3218 Market Cap
TPEX:3218 has a market cap or net worth of 15.04 billion as of September 2, 2025. Its market cap has decreased by -23.49% in one year.
Market Cap
15.04B
Enterprise Value
14.66B
Revenue
4.26B
Ranking
n/a
PE Ratio
17.00
Stock Price
179.00
Market Cap Chart
Since November 3, 2008, TPEX:3218's market cap has increased from 1.01B to 15.04B, an increase of 1,395.75%. That is a compound annual growth rate of 17.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 15.04B | -11.25% |
| Dec 31, 2024 | 16.94B | -27.80% |
| Dec 29, 2023 | 23.47B | -1.63% |
| Dec 30, 2022 | 23.86B | 10.75% |
| Dec 30, 2021 | 21.54B | 18.41% |
| Dec 31, 2020 | 18.19B | 254.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 313.31B |
| PharmaEssentia | 165.47B |
| Bora Pharmaceuticals Co., LTD. | 90.22B |
| Lotus Pharmaceutical | 50.89B |
| Oneness Biotech | 33.48B |
| Lumosa Therapeutics | 32.18B |
| Polaris Group | 30.09B |
| Center Laboratories | 26.43B |